Search details
1.
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis.
Hepatology
; 79(4): 813-828, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-37774387
2.
Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab.
Hepatology
; 79(1): 49-60, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37870270
3.
EASL position paper on clinical follow-up after HCV cure.
J Hepatol
; 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38845253
4.
Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study.
J Hepatol
; 80(4): 543-552, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38092157
5.
Screening of liver cancer with abbreviated MRI.
Hepatology
; 78(2): 670-686, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-36896975
6.
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver Int
; 44(6): 1363-1372, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38436538
7.
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
Liver Int
; 44(6): 1464-1473, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38581233
8.
Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisions.
J Hepatol
; 79(5): 1332-1337, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37210001
9.
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance.
J Hepatol
; 79(1): 226-239, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36854345
10.
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
J Hepatol
; 79(6): 1450-1458, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37647991
11.
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.
J Hepatol
; 78(3): 584-595, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36427656
12.
Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patients.
J Viral Hepat
; 30(6): 567-577, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36891763
13.
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
Liver Int
; 43(3): 546-557, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36571256
14.
Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
Pharmacoepidemiol Drug Saf
; 32(4): 486-495, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36444965
15.
Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical Trial.
JAMA
; 329(18): 1558-1566, 2023 05 09.
Article
in English
| MEDLINE | ID: mdl-37159035
16.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Article
in English
| MEDLINE | ID: mdl-33741640
17.
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
Lancet Oncol
; 23(1): 161-171, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34902334
18.
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
J Hepatol
; 77(1): 128-139, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35139400
19.
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.
J Hepatol
; 76(2): 275-282, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34656649
20.
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
Hepatology
; 74(1): 364-378, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33345307